Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00296426 · ClinicalTrials.gov registry record · NA
Implementation and Evaluation of a Medical Reconciliation Protocol at Brigham and Women's Hospital
A NA study of Medication Reconciliation, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 322
- Enrollment target
- 1
- Study location
NCT00296426 is a NA study of Medication Reconciliation that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 322 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00296426, a NA study of Medication Reconciliation, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 322 participants
- Enrollment target
- 1
- Study location
Study Summary
An incomplete understanding of patients' preadmission medications and failure to reconcile these with medications ordered in the hospital and at discharge are major, previously unappreciated, causes of adverse drug events (ADEs). The Joint Commission for Accreditation of Healthcare Organizations has now mandated a process for reconciling all medications at hospital admission and discharge. The best ways to implement medication reconciliation and the impact on patient outcomes are unknown. We, the researchers at at Brigham and Women's Hospital, will design and implement a medication reconciliation process with two major components: 1) information technology to integrate medication reconciliation into the current workflow at Brigham and Women's Hospital (BWH); and 2) process re-design involving physicians, nurses, and pharmacists to ensure that reconciliation takes place. We will then conduct a randomized controlled trial on the General Medical Service of BWH to evaluate the effects of this new process on reducing medication reconciliation errors with the potential to cause patient harm (potential ADEs).
Conditions Studied
Interventions
- PROCEDURE New technology - PAML
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2006-05 |
| Est. Completion | 2010-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00296426
The ClinicalTrials.gov registry entry for NCT00296426 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 322 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Medication Reconciliation appearing as the primary indexed condition, and to 1 intervention - of which New technology - PAML is the first listed.
NCT00296426 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00296426 about?
NCT00296426 is a clinical study titled "Implementation and Evaluation of a Medical Reconciliation Protocol at Brigham and Women's Hospital". An incomplete understanding of patients' preadmission medications and failure to reconcile these with medications ordered in the hospital and at discharge are major, previously unappreciated, causes of adverse drug events (ADEs). The Joint Commission for Accreditation of Healthcare Organizations has...
What is the current status of trial NCT00296426?
This trial is currently completed. It is a NA study. The enrollment target is 322 participants. The study started on 2006-05. Estimated completion is 2010-08.
What conditions does trial NCT00296426 study?
This clinical trial studies the following conditions: Medication Reconciliation.
What interventions are being tested in trial NCT00296426?
The interventions under investigation include: New technology - PAML (PROCEDURE).
Who is sponsoring clinical trial NCT00296426?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00296426 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.